TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today its intention to issue $2,000,000,000 (equivalent) of senior ...

(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) Monday announced a plan to issue $2 million of senior notes through its special purpose finance subsidiaries. The Israel multinational pharma ...

So when she searched her family’s doctors in Open Payments, a public database that shows which doctors have received money from Big Pharma, Doyle was curious about what she’d find. “ ...

SARASOTA, FL, May 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ("Silo” or the "Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug ...

Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company, announced the dosing of the first patient in the phase 2 pulmonary hypertension-associated interstitial lung disease (PH-ILD) ...

SAN RAFAEL, Calif. and BOSTON, May 16, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Inozyme Pharma, Inc. (Nasdaq: INZY) announced today that BioMarin has entered into a ...

SAN RAFAEL, Calif. and BOSTON, May 16, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Inozyme Pharma, Inc. (Nasdaq: INZY) announced today that BioMarin has entered into a ...

Drugmaker Lupin has received U.S. Food and Drug Administration (U.S. FDA) approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg, its generic version of Janssen Pharmaceuticals’ blood ...

Teva Pharmaceutical Industries Limited (TEVA)’s share was trading at $16.89 as of May 14th. TEVA’s forward P/E is 6.47 according to Yahoo Finance. Teva Pharmaceuticals, the world’s largest ...

In the same period of the previous year, EBITDA amounted to EUR 1.0 million. “In the first quarter of 2025, APONTIS PHARMA continued the growth of previous quarters. The reorganisation of the company, ...

TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody’s Investor Services (“Moody’s”) has raised the company’s ...

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy Teva Pharmaceutical Industries Ltd - (GLOBE NEWSWIRE) May 15, 2025 ...